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Methods for setting priorities in systematic reviewsDevelopment and assessment of methods for setting pri-
orities for systematic reviews is developing into a field of
increasing interest amongst such groups as the AHRQ
and NICE [1,2]. The Cochrane Collaboration has recently
established a new Methods group entitled the ‘‘Cochrane
Agenda and Priority Setting Methods Group’’ to develop
methodology and advise The Cochrane Collaboration on
how the validity and precision of systematic reviews can
be improved. Over the last several years, the Cochrane Col-
laboration has recognized the need for a more accountable
and systematic approach to selecting research questions for
systematic reviews. When the Cochrane Collaboration was
established 20 years ago (the 20th year celebration will take
place at the Quebec City Cochrane Colloquium in Septem-
ber of this year) the topic selection was ‘expert/investiga-
tor-driven,’ in that the authors conducted systematic
reviews on topics they were interested in. The enthusiasm
of these expert authors was one reason the Cochrane
Collaboration has been so successful, with the over 4000
systematic reviews in the Cochrane Library. However,
a more systematic approach is needed to address gaps of
importance to patients, practitioners, and policymakers.
The Collaboration recognized this and in 2007, they estab-
lished a one-off initiative entitled the ‘‘Prioritization Fund,’’
which would suggest mechanisms for improving the rele-
vance of Cochrane Reviews. In this month’s issue of the
Journal of Clinical Epidemiology, we have some of the
products of this initiative. Following two commentaries
on the importance of prioritizing systematic review ques-
tions, there are six reviews and original articles that report
the results of several of the Prioritization Fund projects.
The purpose of the first study in the series was to assess
the presence and effectiveness of existing systems of prior-
itization for Cochrane review topics and to explore methods
of improving those systems. Nasser et al found that only 29
of the 66 Cochrane groups surveyed had a prioritization
system in place for reviews, some of which were more
detailed than others. This is accompanied by an increasing
interest in moving from a totally ‘push model,’ where au-
thors write about what they are interested in, toward an ‘ex-
change model’ where the user, whether patient, practitioner,
or policymaker, provide information on the gaps where
systematic reviews are needed. They urge that all Cochrane
entities should have strategic plans to improve the inclu-
siveness and transparency of their own prioritization pro-
cesses and make more effective use of feedback from end0895-4356  2013 Elsevier Inc.
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Open access under CC BY-NC-ND license.users to increase the likelihood of producing reviews that
have positive effects on health outcomes. Buckley et al as-
sessed the effect of a research prioritization partnership be-
tween clinicians and patients with urinary incontinence. A
partnership of eight patient and 13 clinician organizations
identified and prioritized gaps in the evidence that affect
everyday decisions about treatment. Their top priorities
were published and reported to research funders. They re-
ported that a year later there were 19 products (primary
studies, systematic reviews) under consideration by a na-
tional research commissioning body. Thus, prioritization
through patient-clinician consensus can be effective in in-
forming the development of clinically useful research.
Priority setting needs to be collaborative: Handoll et al
demonstrated the feasibility and potential benefits of a struc-
tured collaboration between a Cochrane Review Group
(specialist-area group responsible for producing Cochrane
reviews) and Cochrane Fields (broad-spectrum interest
groups) for the identification and production of Cochrane
reviews on priority topics. Clavisi et al present the Global
Evidence Mapping multistep multi-method approach for
identifying priority research areas; this involves multiple
stakeholders in an initial scoping meeting and preliminary
literature search, followed by a facilitated mapping work-
shop and an online survey. Jaramillo et al extended this
Global Evidence Mapping priority setting approach to in-
corporate health equity and the social determinants of
health, and showed the utility for patients and practitioners
in developing priorities and refining these into ‘PICO’
questions suitable for a systematic review on interventions
for osteoarthritis. Nasser et al report on the development
and pilot of an equity lens checklist that could help re-
searchers in developing a more equity-oriented approach
toward priority setting and agenda setting in systematic
reviews.
A variant of this priority setting for systematic reviews
is to use systematic reviews to identify research needs
for primary studies (both randomized controlled trials
[RCTs] and observational) [3]. In the latest in articles
from the AHRQ program, Saldanha et al developed and
pilot tested a process to identify needs for primary clinical
research using a systematic review in gestational diabetes
mellitus. In the accompanying commentary, Nasser and
Welch argue for more valuation of such approaches and
stress the importance of patients being part of the stake-
holder group.
468 Editorial / Journal of Clinical Epidemiology 66 (2013) 467e468Turning to other papers in this issue: Selective reporting
in trial reports and systematic reviews is attracting ongoing
attention so systematic approaches to this are needed. The
review by Page et al catalogue the ways in which selective
inclusion and reporting bias can occur in RCTs and system-
atic reviews. They found numerous examples of scenarios
in which multiple outcomes or multiple data for the same
outcome are available, yet only a subset is included or
reported; outcome data are reported with inadequate detail;
or outcome data are given different prominence through its
placement across or within reports. They propose eight cat-
egories each for the following three bias types: selective re-
porting in RCTs, selective inclusion in systematic reviews,
and selective reporting in systematic reviews. They posit
that increasing trialists’ and systematic reviewers’ aware-
ness of these examples may minimize their occurrence.
Two papers on patient-reported instruments bring out
different methodological issues. ‘Sensibility’ is not a com-
mon term nowadays, although it was proposed as a term to
cover face/content validity and feasibility by Alvan Fein-
stein, a former editor of this Journal in 1987 in his seminal
text ‘‘Clinimetrics’’[4]. He used it to emphasize that
these aspects of clinical importance are as important as sta-
tistical significance that is prominent in psychometrice
based assessments. In their article in this issue, Tang et al
have operationalized sensibility as the following four com-
ponents: comprehensiveness, understandability, length, and
suitability of response options as the framework with which
to examine and compare the sensibility attributes (face/con-
tent validity and feasibility) of five at-work productivity
measures from the perspective of patients with osteoarthri-
tis (OA) or rheumatoid arthritis (RA). They found unique
strengths and limitations of the competing five at-work pro-
ductivity measures across the different sensibility criteria.
The second patient-reported outcome paper, by Wong
et al, addresses the ongoing debate and choice of generic
versus disease-specific patient-reported outcome instru-
ments. They sought to examine the responsiveness of ge-
neric and condition-specific instruments based on the
anchor of self-reported level of global change in patients
with colorectal cancer. The authors found that condition-
specific measures were more responsive than all genericsubscales, with the exception of the social domain. The
authors recommend that complementary use of condition-
specific and generic instruments to evaluate the health-
related quality of life of colorectal cancer patients should
be encouraged.
Gold-standard versus silver (surrogate) standards in di-
agnostic test assessments: Kang et al present evidence to
show that evaluating new diagnostic tests presents a chal-
lenge if the conventional ‘‘gold’’ standard is invasive, haz-
ardous, or expensive, especially if that test has been
supplanted in usual clinical practice by a ‘‘silver’’ standard
test that is more acceptable and perhaps only slightly sub-
optimal. They showed that methods ignoring the difference
in reference tests severely underestimated sensitivity and
specificity under the assumption of conditional indepen-
dence. They propose modern Bayesian methods to solve
this.
Lastly, in a novel study of a ‘hard-to-reach’ population
of ex-prisoners, David et al sought to identify determinants
of attrition to determine attrition prevention strategies.
They found a doseeresponse effect of the number of tele-
phone contacts in reducing attrition.
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